Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFSWEB INCPFSW · Entity 108798 | 10% owner | December 28, 2022 | December 30, 2022 |
| Stagwell IncSTGW · Entity 4480 | Director | October 01, 2026 | October 02, 2026 |
| Theravance Biopharma, Inc.tbph · Entity 5037 | 10% owner | July 06, 2026 | July 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFSWEB INC
Report date December 28, 2022 · Filed December 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 2,633,189 |
Last balance in matching sequence
After 2022-12-29 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2022-12-28 · Sale · Disposed 1,750,000 · Balance 883,189 F1: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Row 2 · 2022-12-28 · Purchase · Acquired 1,750,000 · Balance 2,633,189 F1: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Row 3 · 2022-12-29 · Sale · Disposed 883,000 · Balance 1,750,189 F1: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Row 4 · 2022-12-29 · Purchase · Acquired 883,000 · Balance 2,633,189 F1: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities.
Stagwell Inc
Report date October 01, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 173,221 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 2,457 · Balance 173,221 F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 8,014,322 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 8,014,322 F2: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment.
F2: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.
Theravance Biopharma, Inc.
Report date July 06, 2026 · Filed July 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| COMSEC Table I · non-derivative | IndirectSee Footnotes | 9,167,489 |
Last balance in matching sequence
After 2026-07-07 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-07-06 · Sale · Disposed 1,400 · Balance 9,173,053 F1: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Row 2 · 2026-07-07 · Sale · Disposed 5,564 · Balance 9,167,489 F2: The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.
F2: The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SYNOVUS FINANCIAL CORP
Report date June 10, 2024 · Filed June 11, 2024
Section 16 reporting ended · disclosed 2024-06-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Fixed-Rate Reset Non-Cumulative Perpetual Preferred Series ESEC Table I · non-derivative | IndirectSee Footnote | 1,293,259 |
Reported balance
After 2024-06-10 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-06-10 · Sale · Disposed 172,889 · Balance 1,293,259 F1: The sales price reported in Column 4 is a weighted average price. These shares were sales in multiple transactions at prices ranging from $25.20 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales price reported in Column 4 is a weighted average price. These shares were sales in multiple transactions at prices ranging from $25.20 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 01, 2026 Filed Oct 2, 2026 21:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 2,457 | $8.14 | $19,999.98 |
DisclosureSEC source: 0001104659-26-113377 · tm2626793-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,221 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| July 07, 2026 Filed Jul 8, 2026 20:13 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | SaleCOM | 5,564 | $17.17 | $95,540.56 |
DisclosureSEC source: 0001877589-26-000002 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,167,489 F2 · price: The sales price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.17 to $17.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| July 06, 2026 Filed Jul 8, 2026 20:13 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | SaleCOM | 1,400 | $17.04 | $23,856.00 |
DisclosureSEC source: 0001877589-26-000002 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,173,053 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| July 01, 2026 Filed Jul 1, 2026 23:33 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | SaleCOM | 37,799 | $17.00 | $642,628.36 |
DisclosureSEC source: 0001877589-26-000001 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,174,453 F3 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.00 to $17.015, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 20:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 2,691 | $7.43 | $19,994.13 |
DisclosureSEC source: 0001104659-26-080360 · tm2619550-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,764 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| June 30, 2026 Filed Jul 1, 2026 23:33 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | SaleCOM | 25,027 | $17.13 | $428,787.59 |
DisclosureSEC source: 0001877589-26-000001 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,212,252 F2 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.13 to $17.145, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 29, 2026 Filed Jul 1, 2026 23:33 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | SaleCOM | 273,871 | $17.23 | $4,720,139.30 |
DisclosureSEC source: 0001877589-26-000001 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,237,279 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.07 to $17.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 22:03 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 22,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-073622 · tm2617832-4_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 168,073 F1 · shares: The reporting person was awarded restricted stock units as a component of non-employee director compensation. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will vest in full on the first anniversary of the date of grant. Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 3,180 | $6.29 | $20,002.20 |
DisclosureSEC source: 0001104659-26-039195 · tm2610915-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,103 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 21:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 4,090 | $4.89 | $20,000.10 |
DisclosureSEC source: 0001104659-26-000650 · tm261855-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,923 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:31 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 3,552 | $5.63 | $19,997.76 |
DisclosureSEC source: 0001104659-25-096098 · tm2527754-2_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,833 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| July 01, 2025 Filed Jul 1, 2025 20:51 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 4,444 | $4.50 | $19,998.00 |
DisclosureSEC source: 0001104659-25-064781 · tm2519524-2_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,281 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 22:04 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-059967 · tm2518047-6_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,837 F1 · shares: The reporting person was awarded restricted stock units as a component of non-employee director compensation. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will vest in full on the first anniversary of the date of grant. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:42 UTC | Stagwell Inc STGW · Entity 4480 | PurchaseClass A Common Stock | 240,000 | $4.43 | $1,063,200.00 |
DisclosureSEC source: 0001104659-25-057387 · tm2517432-1_4seq1.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 8,014,322 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 04, 2025 Filed Jun 6, 2025 20:42 UTC | Stagwell Inc STGW · Entity 4480 | PurchaseClass A Common Stock | 425,757 | $4.27 | $1,817,982.39 |
DisclosureSEC source: 0001104659-25-057387 · tm2517432-1_4seq1.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 7,774,322 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:01 UTC | Stagwell Inc STGW · Entity 4480 | PurchaseClass A Common Stock | 200,903 | $4.76 | $956,318.37 |
DisclosureSEC source: 0001104659-25-047885 · tm2514945-2_4seq1.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 7,348,565 F1 · shares: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.69 to $4.86, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 23:10 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 3,305 | $6.05 | $19,995.25 |
DisclosureSEC source: 0001104659-25-031310 · tm2510911-7_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,837 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| January 02, 2025 Filed Jan 10, 2025 21:15 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 3,040 | $6.58 | $20,003.20 |
DisclosureSEC source: 0001104659-25-002549 · tm252766-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,532 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| October 01, 2024 Filed Oct 3, 2024 20:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 2,849 | $7.02 | $19,999.98 |
DisclosureSEC source: 0001104659-24-105869 · tm2425534-1_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,492 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common stock on the trading day immediately preceding the date of payment. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 22:02 UTC | Theravance Biopharma, Inc. tbph · Entity 5037 | PurchaseCOM | 999,800 | $7.80 | $7,798,440.00 |
DisclosureSEC source: 0001877589-24-000006 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 9,511,150 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 17:30 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 2,933 | $6.82 | $20,003.06 |
DisclosureSEC source: 0001104659-24-077694 · tm2418858-2_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,643 F1 · shares: Pursuant to the Issuer's Non-Employee Director Compensation Policy, the reporting person elected to receive payment of quarterly fees for service on the Issuer's Board of Directors in shares of fully vested Class A Common Stock in lieu of a cash payment. The number of shares was calculated based on a $20,000 fee divided by the closing price of the Class A Common Stock on the trading day immediately preceding the date of payment. Read SEC document |
| June 12, 2024 Filed Jun 15, 2024 00:02 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 22,762 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-071879 · tm2417338-4_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,710 F1 · shares: The reporting person was awarded restricted stock units as a component of non-employee director compensation. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will vest in full on the first anniversary of the date of grant. Read SEC document |
| June 10, 2024 Filed Jun 11, 2024 16:18 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 172,889 | $25.20 | $4,357,321.47 |
DisclosureSEC source: 0001877589-24-000005 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,293,259 F1 · price: The sales price reported in Column 4 is a weighted average price. These shares were sales in multiple transactions at prices ranging from $25.20 to $25.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 07, 2024 Filed Jun 7, 2024 17:28 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 20 | $25.20 | $504.00 |
DisclosureSEC source: 0001877589-24-000004 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,466,148 F3 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 17:28 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 325 | $25.24 | $8,202.61 |
DisclosureSEC source: 0001877589-24-000004 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,466,168 F2 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.22 to $25.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 17:28 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 6,803 | $25.22 | $171,544.45 |
DisclosureSEC source: 0001877589-24-000004 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,466,493 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.20 to $25.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 04, 2024 Filed Jun 4, 2024 17:21 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 6,278 | $25.23 | $158,395.20 |
DisclosureSEC source: 0001877589-24-000003 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,473,296 F3 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.20 to $25.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 17:21 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 13,685 | $25.23 | $345,324.55 |
DisclosureSEC source: 0001877589-24-000003 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,479,574 F2 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.20 to $25.27, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 17:21 UTC | SYNOVUS FINANCIAL CORP SNV PR E · Entity 70670 | SaleFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 200,000 | $25.07 | $5,014,900.00 |
DisclosureSEC source: 0001877589-24-000003 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,493,259 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.99 to $25.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:19 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | PurchaseCOM | 499,324 | $8.75 | $4,369,085.00 |
DisclosureSEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,511,350 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 01, 2024 Filed May 3, 2024 20:19 UTC | Theravance Biopharma, Inc. TBPH · Entity 5037 | PurchaseCOM | 999,800 | $8.75 | $8,748,250.00 |
DisclosureSEC source: 0001877589-24-000001 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 8,012,026 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 20, 2023 Filed Oct 24, 2023 16:29 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 560 | $21.35 | $11,956.00 |
DisclosureSEC source: 0001877589-23-000008 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,693,259 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 16:12 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 4,279 | $21.50 | $91,998.50 |
DisclosureSEC source: 0001877589-23-000007 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,692,699 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 12, 2023 Filed Oct 16, 2023 16:12 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 235 | $21.50 | $5,052.50 |
DisclosureSEC source: 0001877589-23-000007 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,688,420 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 11, 2023 Filed Oct 11, 2023 16:52 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 881 | $21.50 | $18,941.50 |
DisclosureSEC source: 0001877589-23-000006 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,688,185 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:52 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 1,072 | $21.50 | $23,048.00 |
DisclosureSEC source: 0001877589-23-000006 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,687,304 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 16:52 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 957 | $21.15 | $20,240.55 |
DisclosureSEC source: 0001877589-23-000006 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,686,232 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 17:20 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 3,466 | $21.28 | $73,756.48 |
DisclosureSEC source: 0001877589-23-000005 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,685,275 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.20 to $21.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 27, 2023 Filed Sep 28, 2023 17:06 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 12,196 | $21.30 | $259,774.80 |
DisclosureSEC source: 0001877589-23-000004 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,681,809 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.275 to $21.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 26, 2023 Filed Sep 26, 2023 16:29 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 9,633 | $21.30 | $205,182.90 |
DisclosureSEC source: 0001877589-23-000003 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,669,613 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 25, 2023 Filed Sep 26, 2023 16:29 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 7,553 | $21.30 | $160,878.90 |
DisclosureSEC source: 0001877589-23-000003 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,659,980 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 22, 2023 Filed Sep 26, 2023 16:29 UTC | SYNOVUS FINANCIAL CORP SNV PRE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 9,036 | $21.30 | $192,466.80 |
DisclosureSEC source: 0001877589-23-000003 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,652,427 F1 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 21, 2023 Filed Sep 21, 2023 17:17 UTC | SYNOVUS FINANCIAL CORP SNV PrE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 8,884 | $21.25 | $188,788.55 |
DisclosureSEC source: 0001877589-23-000002 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,643,391 F3 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.25 to $21.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
| September 20, 2023 Filed Sep 21, 2023 17:17 UTC | SYNOVUS FINANCIAL CORP SNV PrE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 36,425 | $21.40 | $779,495.00 |
DisclosureSEC source: 0001877589-23-000002 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,634,507 F2 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.38 to $21.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
| September 19, 2023 Filed Sep 21, 2023 17:17 UTC | SYNOVUS FINANCIAL CORP SNV PrE · Entity 70670 | PurchaseFixed-Rate Reset Non-Cumulative Perpetual Preferred Series E | 197,705 | $21.40 | $4,230,333.43 |
DisclosureSEC source: 0001877589-23-000002 · primary_doc.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnotes Disclosed balance after: 1,598,082 F1 · price: The purchase price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.35 to $21.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:25 UTC | Stagwell Inc STGW · Entity 4480 | GrantClass A Common Stock | 18,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072387 · tm2318971-3_4seq1.xml · nonDerivative · entry 1 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,948 F1 · shares: The reporting person was awarded restricted stock units as a component of non-employee director compensation. Each restricted stock unit represents a contingent right to receive one share of Class A Common Stock. The restricted stock units will vest in full on the first anniversary of the date of grant. Read SEC document |
| March 10, 2023 Filed Mar 14, 2023 21:01 UTC | Stagwell Inc STGW · Entity 4480 | PurchaseClass A Common Stock | 750,000 | $6.75 | $5,062,500.00 |
DisclosureSEC source: 0001104659-23-032340 · tm239523-3_4seq1.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,147,662 F1 · price: The reported securities were purchased by funds managed by Madison Avenue Partners, LP in an underwritten public offering at $6.75 per share. F2 · ownership.nature: These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities. Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 16:59 UTC | PFSWEB INC PFSW · Entity 108798 | PurchaseCommon Stock | 883,000 | $6.00 | $5,298,000.00 |
DisclosureSEC source: 0001877589-22-000007 · primary_doc.xml · nonDerivative · entry 4 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,633,189 F1 · ownership.nature: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
| December 29, 2022 Filed Dec 30, 2022 16:59 UTC | PFSWEB INC PFSW · Entity 108798 | SaleCommon Stock | 883,000 | $6.00 | $5,298,000.00 |
DisclosureSEC source: 0001877589-22-000007 · primary_doc.xml · nonDerivative · entry 3 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,750,189 F1 · ownership.nature: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
| December 28, 2022 Filed Dec 30, 2022 16:59 UTC | PFSWEB INC PFSW · Entity 108798 | PurchaseCommon Stock | 1,750,000 | $5.92 | $10,360,000.00 |
DisclosureSEC source: 0001877589-22-000007 · primary_doc.xml · nonDerivative · entry 2 Samaha Eli · CIK 0001877589 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,633,189 F1 · ownership.nature: The shares are held by funds managed by Madison Avenue Partners, LP. The Reporting person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.